Based on the
information you provided, we found the following studies.
Phase I Study of the Safety and Tolerability of ATR-101 in Adrenocortical CarcinomaThis study will evaluate the safety of an investigational drug called ATR-101 and determine the highest safe dose that can be administered in adult participants with adrenocortical cancer that have failed standard chemotherapy.This study is researching all of the following topics:Adrenal cancer
This study is looking for:
both men and women
Volunteers with specific conditions